慢性乙型肝炎的药理管理方面的进展
Cella Danielescu1, Monica State1, Radu Bogdan Mateescu1,2
1Gastroenterology Department, Colentina Clinical Hospital, Bucharest, Romania; and.
American journal of therapeutics
|March 28, 2024
概括
目前的乙型肝炎治疗抑制病毒,但不能治愈它. 像贝皮罗病毒这样的新疗法正在开发中,以实现B型肝炎感染的功能治疗,旨在在2030年之前根除.
科学领域:
- 肝病学和病毒学研究.
- 开发新的抗病毒疗法.
- 全球公共卫生倡议致力于根除传染病.
背景情况:
- 乙型肝炎病毒 (HBV) 感染是一个重大的全球健康问题.
- 疫苗可以预防,但仍然是一个持续的挑战.
- 目前的工作重点是到2030年实现功能性治疗.
研究的目的:
- 审查目前对乙型肝炎病毒 (HBV) 感染的治疗方法.
- 探索HBV功能治愈的新型治疗策略.
- 评估新药在根除HBV方面的潜力.
主要方法:
- 在主要的科学数据库和临床试验注册表中进行全面的文献搜索.
- 包括同行评审的文章和关于HBV管理和治疗的灰色文献.
- 对现有和新兴HBV治疗方法的数据分析.
主要成果:
- 现有的核酸/核酸模拟疗法在实现功能治愈方面取得了有限的成功 (<5%的HBsAg损失).
- 新型疗法,包括小干扰RNA和贝皮罗病毒,显示出有前途.
- 贝皮罗病毒呈现出良好的安全性,需要进一步调查.
结论:
- 目前的治疗方法还不能完全消除HBV感染.
- 像bepirovirsen这样的创新治疗对于功能性治疗至关重要.
- 新疗法旨在减少与HBV相关的发病率和死亡率,包括肝硬化和肝癌.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Chronic Pancreatitis II: Collaborative Care
86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
86
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
38
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
38
Diabetes: Management and Pharmacotherapy
277
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
277
Gastritis III: Clinical Manifestations and Management
235
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
235
Acute Pancreatitis II: Clinical Manifestations and Management
122
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
122


